PitchSend

Investor Presentaiton

Pipeline Outlook Timeline ✓ 3 generic APIs launched ✓ 3 in-house drug ANDAs filed ✓ 1st BD & 1st self-developed US ANDA launched ✓ 3 NDAs filed by CRAM customers ✓ 5-7 generic APIs launched ✓ 2 co-developed China ANDAS ✓ 3 APIs by CRAM customers launched 34 =4 2018 2019 2020 2021 ✓ 5-7 generic APIs launched ✓ 1 BD US ANDA launched ✓ 3 APIs by CRAM customers launched ✓ US FDA inspection at Injectable plant ✓ CFDA inspection at Changshu site ✓ 6-8 generic APIs launched ✓ 3 BD & 1 self-developed ANDA launched ✓ 5 APIs by CRAM customers launched ScinoPharm

View entire presentation